Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spironolactone in Chronic Kidney Disease Enabled by Chlorthalidone: A Pilot Randomized Control Trial

NCT05222191 is registered in ClinicalTrials.gov with Indiana Institute for Medical Research as lead sponsor.

NCT NCT05222191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05222191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spironolactone in Chronic Kidney Disease Enabled by Chlorthalidone: A Pilot Randomized Control Trial
Lead sponsor
Indiana Institute for Medical Research
Phase
Phase 2
Overall status
Unknown status
Start date
February 1, 2022
Completion date
December 12, 2023
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hypertension, renal insufficiency